Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Comprehensive Segmental Revision System

NCT: NCT03270982 · ACTIVE_NOT_RECRUITING

NCT IDNCT03270982
StatusACTIVE_NOT_RECRUITING
Start Date2016-04
Completion2035-12
SponsorZimmer Biomet (INDUSTRY)
First posted
Last updated

Brief Summary

Clinical Data evaluation to document the performance and clinical outcomes of the Comprehensive Segmental Revision System.

Frequently Asked Questions

What is Comprehensive Segmental Revision System?

Comprehensive Segmental Revision System is a clinical trial registered under NCT03270982. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03270982?

The current status of NCT03270982 (Comprehensive Segmental Revision System) is: ACTIVE_NOT_RECRUITING.

When did Comprehensive Segmental Revision System start?

Comprehensive Segmental Revision System started on 2016-04.

Related Devices

K243293Zimmer® Persona® Personalized Knee SystemZimmer Biomet K243571Trabecular Metal Acetabular Revision System, Acetabular Liners and Constrained LinersZimmer Biomet K251620A.L.P.S. Proximal Humerus Plating SystemZimmer Biomet K251834Persona Partial KneeZimmer Biomet K173411Comprehensive Segmental Revision System (SRS)Biomet Manufacturing Corp

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑